Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...

Pfizer introduces its next-gen 20-valent pneumococcal conjugate vaccine (PCV20) in India for adult immunization against 20 ...

Pfizer's share price gained today after the company announced the launch of its next-generation 20-valent pneumococcal ...

Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes, including both invasive and non ...

PCV20 will be available as a single-shot vaccine and those vaccinated with PCV20 may not need a second dose, the drug maker ...

Pfizer Malaysia announced that its 20-valent pneumococcal conjugate vaccine (PCV20) has been approved by the Ministry of ...

Stocks like Highway Infrastructure, Hindalco Industries, Pfizer, Medi Assist, Adani Enterprises, and HG Infra Engineering ...

Pfizer has introduced its 20-valent pneumococcal conjugate vaccine, PCV20, in India to provide protection against 20 serotypes of pneumococcal disease. The single-shot vaccine is aimed at adults, ...

The NSE Nifty 50 ended 221.75 points or 0.91% higher at 24,585.05 and the BSE Sensex ended 746.29 points or 0.93% up at ...

The Korea Disease Control and Prevention Agency announced on 4th that it plans to implement free vaccinations for the 20-valent pneumococcal conjugate vaccine (PCV20) starting from Oct. 1. The target ...

Indian benchmarks indices, the BSE Sensex and NSE Nifty, are set to open in positive terrain on Tuesday, taking firm cues ...